1. Signaling Pathways
  2. GPCR/G Protein
    Neuronal Signaling
  3. Orexin Receptor (OX Receptor)
  4. Orexin Receptor (OX Receptor) Inhibitor

Orexin Receptor (OX Receptor) Inhibitor

Orexin Receptor (OX Receptor) Inhibitors (9):

Cat. No. Product Name Effect Purity
  • HY-P99836
    Cudarolimab
    Inhibitor
    Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has antitumor activity and can be used in cancer related research.
  • HY-123176
    GYKI-13380
    Inhibitor
    GYKI-13380 is an appetite suppressant. GYKI-13380 has the potential for the research of neurology diseases.
  • HY-P991338
    MEDI-6469
    Inhibitor
    MEDI-6469 is a human monoclonal antibody (mAb) targeting TNFRSF4/OX40/CD134. MEDI-6469 targets the OX40 receptor on activated T cells to enhance the immune response against cancer cells..
  • HY-P991335
    BAT6026
    Inhibitor
    BAT6026 is a human monoclonal antibody (mAb) targeting TNFRSF4/OX40/CD134. BAT6026 significantly reduces Treg cells and increased CD8+ T cells in tumor.
  • HY-P991339
    ZL-1101
    Inhibitor
    ZL-1101 is a human monoclonal antibody (mAb) targeting TNFRSF4/OX40/CD134.
  • HY-P990479
    Anti-OX2R/CD200R1 Antibody
    Inhibitor
    Anti-OX2R/CD200R1 Antibody is a CHO-expressed human antibody that targets OX2R/CD200R1. The predicted molecular weight (MW) of Anti-OX2R/CD200R1 Antibody is 146.58 kDa. The isotype control for Anti-OX2R/CD200R1 Antibody can refer to Human IgG4 kappa, Isotype Control (HY-P99003).
  • HY-P991337
    YH-002
    Inhibitor
    YH-002 is a human IgG1 monoclonal antibody (mAb) targeting TNFRSF4/OX40/CD134. YH-002 binds to OX40 by mimicking the function of OX40L.
  • HY-149014
    OX2R-IN-1
    Inhibitor
    OX2R-IN-1 (compound 15) is a low cytotoxicity profile OX2R-IN-1 antagonist (a potential OX2R binder) with an IC50 value of 484 μM. OX2R-IN-1 (compound 15) can cross the BBB into the brain with a short half-life.
  • HY-P991334
    INCAGN1949
    Inhibitor
    INCAGN1949 is a human IgG1 monoclonal antibody (mAb) targeting TNFRSF4/OX40/CD134. INCAGN1949 selectively deplete intratumoral regulatory T cells.